Advertisement

Pain States, the Opioid Epidemic, and the Role of Radiologists

  • Mark R. Jones
  • Alan D. Kaye
  • Laxmaiah Manchikanti
  • Joshua A. Hirsch
Other Pain (A Kaye and N Vadivelu, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Other Pain

Abstract

Purpose of Review

The prevalence of chronic pain and prescription opioid abuse has resulted in epidemic problems for patients and clinicians. The consequences are taking a heavy toll on patients, physicians, and society. Specific to radiology, a significant need exists for best practice assessment and treatment approaches for pain management, as patients with chronic pain often undergo radiological tests of unclear clinical relevance.

Recent Findings

The USA is amid an opioid-prescribing epidemic and resultant overdose public health emergency. A variety of reasons, which are examined in this manuscript, have contributed to the dramatic increase in the use of chronic opioid therapy for chronic non-cancer pain. This increase of opioid prescriptions and related deaths is based on many factors including the perception that there was systemic undertreatment of pain, the philosophical approach of advocacy groups for pain relief, promotion by the pharmaceutical industry, Joint Commission’s Fifth Vital Sign, and permissive regulations by boards of medical licensures promoting excessive use of opioids. Overall, opioid treatment has been based on subjective pain relief and radiographic findings, which may not correlate with the source of pain generation.

Summary

Radiologists, along with interventionalists, frequently interact with patients on chronic opioid therapy and at times take responsibility for patients with chronic pain. Beyond reading studies, diagnostic radiologists provide care to larger percentages of patients taking narcotics than ever before. This manuscript focuses on chronic pain, escalating opioid therapy, and adverse consequences, including the epidemic of overdoses and deaths. Radiologists’ expertise can potentially reduce unnecessary radiological tests and inappropriate prescribing of medications.

Keywords

Opioids Radiology Back pain Chronic pain Imaging 

Notes

Compliance with Ethical Standards

Conflict of Interest

Mark R. Jones declares no conflict of interest. Alan D. Kaye is a speaker for Depomed, Inc. and Merck, Inc.; Laxmaiah Manchikanti has provided limited consulting services to Semnur Pharmaceuticals, Incorporated, which is developing non-particulate steroids. Joshua A. Hirsch is a consultant for Medtronic.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Phys. 2017;20(2S):S3–S92.Google Scholar
  2. 2.
    •• Manchikanti L, Kaye AM, Kaye AD. Current state of opioid therapy and abuse. Curr Pain Headache Rep. 2016;20(5):34. Excellent review on the current state of opioid therapy and opioid abuse CrossRefPubMedGoogle Scholar
  3. 3.
    U.S. Department of Health and Human Services Office of Inspector General. Opioids in Medicare Part D: Concerns about extreme use and questionable prescribing. HHS OIG Data Brief: OEI-02-17-00250. https://oig.hhs.gov/oei/reports/oei-02-17-00250.pdf
  4. 4.
    Guy GP Jr, Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697–704.  https://doi.org/10.15585/mmwr.mm6626a4.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Schneiderhan J, Clauw D, Schwenk TL. Primary care of patients with chronic pain. JAMA. 2017;317(23):2367–8.  https://doi.org/10.1001/jama.2017.5787.CrossRefPubMedGoogle Scholar
  6. 6.
    Schuchat A, Houry D, Guy GP Jr. New data on opioid use and prescribing in the United States. JAMA. 2017;Google Scholar
  7. 7.
    U.S. Burden of Disease Collaborators. The state of US health, 1990 – 2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.CrossRefGoogle Scholar
  8. 8.
    Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627–46.  https://doi.org/10.1001/jama.2016.16885.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Filizola M, Devi LA. Grand opening of structure-guided design for novel opioids. Trends Pharmacol Sci. 2013;34(1):6–12.  https://doi.org/10.1016/j.tips.2012.10.002.CrossRefPubMedGoogle Scholar
  10. 10.
    Jones MR, Kaye AD, Kaye AJ, Urman RD. The emerging therapeutic roles of κ-opioid agonists. J Opioid Manag. 2016;12(2):101–7.  https://doi.org/10.5055/jom.2016.0321.CrossRefPubMedGoogle Scholar
  11. 11.
    Vanderah TW. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain. 2010 Jan;26(Suppl 10):S10–5.  https://doi.org/10.1097/AJP.0b013e3181c49e3a.CrossRefPubMedGoogle Scholar
  12. 12.
    Boswell MV, Manchikanti L, Kaye AD, et al. A best-evidence systematic appraisal of the diagnostic accuracy and utility of facet (zygapophysial) joint injections in chronic spinal pain. Pain Physician. 2015;18(4):E497–533.PubMedGoogle Scholar
  13. 13.
    Manchikanti L, Kaye AD, Boswell MV, et al. A systematic review and best evidence synthesis of the effectiveness of therapeutic facet joint interventions in managing chronic spinal pain. Pain Phys. 2015;18(4):E535–82.Google Scholar
  14. 14.
    •• Kaye AD, Manchikanti L, Abdi S, et al. Efficacy of epidural injections in managing chronic spinal pain: a best evidence synthesis. Pain Physician. 2015;18(6):E939–E1004. Excellent review on efficacy of epidural injections PubMedGoogle Scholar
  15. 15.
    Simopoulos TT, Manchikanti L, Gupta S, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Phys. 2015;18(5):E713–56.Google Scholar
  16. 16.
    •• Grider JS, Manchikanti L, Carayannopoulos A, et al. Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Phys. 2016;19(1):E33–54. Excellent review on efficacy of spinal cord stimulation Google Scholar
  17. 17.
    Manchikanti L, Benyamin RM, Falco FJ, Kaye AD, Hirsch JA. Do epidural injections provide short- and long-term relief for lumbar disc herniation? A systematic review. Clin Orthop Relat Res. 2015;473(6):1940–56.  https://doi.org/10.1007/s11999-014-3490-4.CrossRefPubMedGoogle Scholar
  18. 18.
    Manchikanti L, Nampiaparampil DE, Candido KD, Bakshi S, Grider JS, FJE F, et al. Do cervical epidural injections provide long-term relief in neck and upper extremity pain? A systematic review. Pain Phys. 2015;18(1):39–60.Google Scholar
  19. 19.
    Helm S II, Racz GB, Gerdesmeyer L, et al. Percutaneous and endoscopic adhesiolysis in managing low back and lower extremity pain: a systematic review and meta-analysis. Pain Phys. 2016;19(2):E245–82.Google Scholar
  20. 20.
    Manchikanti L, Datta S, Gupta S, et al. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: part 2. Therapeutic interventions. Pain Phys. 2010;13(4):E215–64.Google Scholar
  21. 21.
    Manchikanti L, Pampati V, Hirsch JA. Retrospective cohort study of usage patterns of epidural injections for spinal pain in the US fee-for-service Medicare population from 2000 to 2014. BMJ Open. 2016;6(12):e013042.  https://doi.org/10.1136/bmjopen-2016-013042.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Manchikanti L, Hirsch JA, Pampati V, Boswell MV. Utilization of facet joint and sacroiliac joint interventions in Medicare population from 2000 to 2014: explosive growth continues. Curr Pain Headache Rep. 2016;20(10):58.  https://doi.org/10.1007/s11916-016-0588-2.CrossRefPubMedGoogle Scholar
  23. 23.
    Manchikanti L, Pampati V, Hirsch JA. Utilization of interventional techniques in managing chronic pain in Medicare population from 2000 to 2014: an analysis of patterns of utilization. Pain Phys. 2016;19(4):E531–46.Google Scholar
  24. 24.
    Hirsch JA, Chandra RV, Pampati V, et al. Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointer Surg. 2016;31Google Scholar
  25. 25.
    Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087.PubMedGoogle Scholar
  26. 26.
    Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manag. 2006;11(1):11–38.  https://doi.org/10.1155/2006/642568.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Patel ND, Broderick DF, Burns J. ACR appropriateness criteria low back pain. J Am Coll Radiol. 2016 Sep;13(9):1069–78.  https://doi.org/10.1016/j.jacr.2016.06.008.CrossRefPubMedGoogle Scholar
  28. 28.
    Lehnert BE, Bree RL. Analysis of appropriateness of outpatient CT and MRI referred from primary care clinics at an academic medical center: how critical is the need for improved decision support? J Am Coll Radiol. 2010;7(3):192–7.  https://doi.org/10.1016/j.jacr.2009.11.010.CrossRefPubMedGoogle Scholar
  29. 29.
    Hom J, Smith CD, Ahuja N, Wintermark M. R-SCAN: imaging for low back pain. J Am Coll Radiol. 2016;13(11):1385–1386.e1.  https://doi.org/10.1016/j.jacr.2016.06.043.CrossRefPubMedGoogle Scholar
  30. 30.
    Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331(2):69–73.  https://doi.org/10.1056/NEJM199407143310201.CrossRefPubMedGoogle Scholar
  31. 31.
    Vu T, Al-Grain H, Liu A, Grim R. The clinical efficacy of repeat magnetic resonance imaging in patients with chronic spine pain, presented at: the American Pain Society 36th Annual Scientific Meeting; May 17-20, 2017; Pittsburgh PA.Google Scholar
  32. 32.
    Srinivas SV, Deyo RA, Berger ZD. Application of “less is more” to low back pain. Arch Intern Med. 2012;172(13):1016–20.  https://doi.org/10.1001/archinternmed.2012.1838.CrossRefPubMedGoogle Scholar
  33. 33.
    Manchikanti L, Atluri S, Hansen H, et al. Opioids in chronic noncancer pain: have we reached a boiling point yet? Pain Phys. 2014;17(1):E1–E10.Google Scholar
  34. 34.
    Rosenkrantz AB, Hirsch JA, Allen B Jr, et al. Identifying radiology’s place in the expanding landscape of episode payment models. J Am Coll Radiol. 2017;Google Scholar
  35. 35.
    Rosenkrantz AB, Nicola GN, Allen B Jr, et al. MACRA, alternative payment models, and the physician-focused payment model: implications for radiology. J Am Coll Radiol. 2017;Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Mark R. Jones
    • 1
  • Alan D. Kaye
    • 2
  • Laxmaiah Manchikanti
    • 3
    • 4
  • Joshua A. Hirsch
    • 5
    • 6
  1. 1.Department of Anesthesiology, Beth Israel HospitalHarvard Medical SchoolBostonUSA
  2. 2.Department of AnesthesiaLSU Health Science CenterNew OrleansUSA
  3. 3.Pain Management Center of PaducahPaducahUSA
  4. 4.Anesthesiology and Perioperative MedicineUniversity of LouisvilleLouisvilleUSA
  5. 5.Department of RadiologyMassachusetts General HospitalBostonUSA
  6. 6.Harvard Medical SchoolBostonUSA

Personalised recommendations